Added to YB: 2026-06-04
Pitch date: 2026-06-02
PCRX.V [neutral]
PharmaCorp Rx Inc.
Author Info
Wolf of Oakville takes a magnifying glass to Canadian small cap stocks. Sign up for the newsletter.
Company Info
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs.
Market Cap
CAD 88.8M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-170.63
P/E
-44.00
EV/Sales
2.92
Sector
Consumer Staples Distribution and Retail
Category
growth
PharmacorpRX FINS Review
PCRX.V (earnings): Q1 rev $7.2M (+79% YoY) from new pharmacies; net income $127k (-50% YoY); GM dipped to 38.7%; opex doubled (monitor). Strong balance sheet: 9.4 current ratio, $23.4M cash, but $32.4M acquisitions (8+ pharmacies) loom—$9M shortfall via credit facility/dilution. 174M shares, 48% dilution in 5 qtrs. Path to 18 pharmacies by 2026. Author adding above $0.49. Three stars.
Read full article (3 min)